NORTHWOOD, OHIO, USA – October, 2013 – NAMSA is pleased to announce the addition of Medipert as NAMSA’s local agent in South Korea. Medipert a regulatory, quality, and clinical consulting firm has been in operations for over 10 years and supported numerous companies on gaining approval for medical devices in Korea. Medipert offers services throughout the Korean medical device market entry process including; market research, distributor identification, medical device regulatory approval, testing support, quality consulting, reimbursement strategy, clinical trial approval, and government affairs. The addition of Medipert as a NAMSA agent demonstrates our commitment to continue to grow the service offerings for our clients around the world.
If you would like to talk to a sales representative from Medipert you can contact them here.